Structural and mutagenic analysis of foot-and-mouth disease virus 3C protease reveals the role of the β-ribbon in proteolysis

Journal of Virology

Volumn 81, Issue 1, 2007, Pages 115-124

  Sweeney, Trevor R ^a   Roqué Rosell, Núria ^a   Birtley, James R ^a   Leatherbarrow, Robin J ^a   Curry, Stephen ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3C PROTEASE; MUTANT PROTEIN; PROTEINASE; VIRUS ENZYME;

ARTICLE; CATALYSIS; CRYSTALLIZATION; DRUG DESIGN; ENZYME ACTIVITY; ENZYME SUBSTRATE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; LIVESTOCK; NONHUMAN; PEPTIDE SYNTHESIS; PICORNAVIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS INFECTION; X RAY DIFFRACTION;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; CYSTEINE ENDOPEPTIDASES; FOOT-AND-MOUTH DISEASE VIRUS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY; VIRAL PROTEINS;

FOOT-AND-MOUTH DISEASE VIRUS;

EID: 33845759346     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01587-06     Document Type: Article

References (38)

1. Allaire, M., M. M. Chernaia, B. A. Malcolm, and M. N. James. 1994. Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. Nature 369:72-76.
2. Atherton, E., and R. C. Sheppard (ed.). 1989. Solid phase peptide synthesis. Oxford University Press, Oxford, United Kingdom.
3. Bergmann, E. M., M. M. Cherney, J. McKendrick, S. Frormann, C. Luo, B. A. Malcolm, J. C. Vederas, and M. N. James. 1999. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotem processing in HAV. Virology 265:153-163.
4. Bergmann, E. M., S. C. Mosimann, M. M. Chernaia, B. A. Malcolm, and M. N. James. 1997. The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition. J. Virol. 71:2436-2448.
5. Birtley, J. R., and S. Curry. 2005. Crystallization of foot-and-mouth disease virus 3C protease: surface mutagenesis and a novel crystal-optimization strategy. Acta Crystallogr. D. 61:646-650.
6. Birtley, J. R., S. R. Knox, A. M. Jaulent, P. Brick, R. J. Leatherbarrow, and S. Curry. 2005. Crystal structure of foot-and-mouth disease virus 3C protease: new insights into catalytic mechanism and cleavage specificity. J. Biol. Chem. 280:11520-11527.
7. Bone, R., D. Frank, C. A. Kettner, and D. A. Agard. 1989. Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates. Biochemistry 28:7600-7609.
8. 7a.Brunger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, R. J. Read, L. M. Rice, T. Simonson, and G. L. Warren. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54:905-921.
9. Carrillo, C., E. R. Tulman, G. Delhon, Z. Lu, A. Carreno, A. Vagnozzi, G. F. Kutish, and D. L. Rock. 2005. Comparative genomics of foot-and-mouth disease virus. J. Virol. 79:6487-6504.
10. Collaborative Computer Project No. 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50:760-763.
11. Delano, W. L. 2002. The PyMOL molecular graphies system. DeLano Scientific, San Carlos, CA.
12. Dragovich, P. S., S. E. Webber, R. E. Babine, S. A. Fuhrman, A. K. Patick, D. A. Matthews, S. H. Reich, J. T. Marakovits, T. J. Prins, R. Zhou, J. Tikhe, E. S. Littlefield, T. M. Bleckman, M. B. Wallace, T. L. Little, C. E. Ford, J. W. Meador III, R. A. Ferre, E. L. Brown, S. L. Binford, D. M. DeLisle, and S. T. Worland. 1998. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. J. Med. Chem. 41:2819-2834.
13. Fersht, A. 1984. Enzyme structure and mechanism, 2nd ed. W. H. Freeman & Co. Ltd., New York, N.Y.
14. Fujinaga, M., L. T. Delbaere, G. D. Brayer, and M. N. James. 1985. Refined structure of alpha-lytic protease at 1.7 Å resolution. Analysis of hydrogen bonding and solvent structure. J. Mol. Biol. 184:479-502.
15. Fujinaga, M., R. J. Read, A. Sielecki, W. Ardelt, M. Laskowski, Jr., and M. N. James. 1982. Refined crystal structure of the molecular complex of Streptomyces griseus protease B, a serine protease, with the third domain of the ovomucoid inhibitor from turkey. Proc. Natl. Acad. Sci. USA 79:4868-4872.
16. Grubman, M. J., and B. Baxt. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493.
17. Hanecak, R., B. L. Semler, H. Ariga, C. W. Anderson, and E. Wimmer. 1984. Expression of a cloned gene segment of poliovirus in E. coli: evidence for autocatalytic production of the viral proteinase. Cell 37:1063-1073.
18. Harmon, S. A., W. Updike, X. Y. Jia, D. F. Summers, and E. Ehrenfeld. 1992. Polyprotein processing in as and in trans by hepatitis A virus 3C protease cloned and expressed in Escherichia coli. J. Virol. 66:5242-5247.
19. James, M. N., A. R. Sielecki, G. D. Brayer, L. T. Delbaere, and C. A. Bauer. 1980. Structures of product and inhibitor complexes of Streptomyces griseus protease A at 1.8 Å resolution. A model for serine protease catalysis. J. Mol. Biol. 144:43-88.
20. Jones, T. A., J. Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these maps. Acta Crystallogr. A 47:110-119.
21. Knowles, N. J., and A. R. Samuel. 2003. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 91:65-80.
22. Leatherbarrow, R. J. 2003. GraFit, 5.0 ed. Erithacus Software Limited, London, United Kingdom.
23. Li, W., N. Ross-Smith, C. G. Proud, and G. J. Belsham. 2001. Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: identification of the eIF4AI cleavage site. FEBS Lett. 507:1-5.
24. Matthews, D. A., P. S. Dragovich, S. E. Webber, S. A. Fuhrman, A. K. Patick, L. S. Zalman, T. F. Hendrickson, R. A. Love, T. J. Prins, J. T. Marakovits, R. Zhou, J. Tikhe, C. E. Ford, J. W. Meador, R. A. Ferre, E. L. Brown, S. L. Binford, M. A. Brothers, D. M. DeLisle, and S. T. Worland. 1999. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. USA 96:11000-11007.
25. Matthews, D. A., W. W. Smith, R. A. Ferre, B. Condon, G. Budahazi, W. Sisson, J. E. Villafranca, C. A. Janson, H. E. McElroy, C. L. Gribskov, and S. Worland. 1994. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 77:761-771.
26. McCoy, A. J., R. W. Grosse-Kunstleve, L. C. Storoni, and R. J. Read. 2005. Likelihood-enhanced fast translation functions. Acta Crystallogr. D 61:458-464.
27. Mosimann, S. C., M. M. Cherney, S. Sia, S. Plotch, and M. N. James. 1997. Refined X-ray crystallographic structure of the poliovirus 3C gene product. J. Mol. Biol. 273:1032-1047.
28. Nayak, A., I. G. Goodfellow, and G. J. Belsham. 2005. Factors required for the uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J. Virol. 79:7698-7706.
29. Nienaber, V. L., K. Breddam, and J. J. Birktoft. 1993. A glutamic acid specific serine protease utilizes a novel histidine triad in substrate binding. Biochemistry 32:11469-11475.
30. Palmenberg, A. C., and R. R. Rueckert. 1982. Evidence for intramolecular self-cleavage of picornaviral replicase precursors. J. Virol. 41:244-249.
31. Petersen, J. F., M. M. Cherney, H. D. Liebig, T. Skern, E. Kuechler, and M. N. James. 1999. The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis. EMBO J. 18:5463-5475.
32. Phan, J., A. Zdanov, A. G. Evdokimov, J. E. Tropea, H. K. Peters III, R. B. Kapust, M. Li, A. Wlodawer, and D. S. Waugh. 2002. Structural basis for the substrate specificity of tobacco etch virus protease. J. Biol. Chem. 277:50564-50572.
33. Richards, O. C., L. A. Ivanoff, K. Bienkowska-Szewczyk, B. Butt, S. R. Petteway, Jr., M. A. Rothstein, and E. Ehrenfeld. 1987. Formation of poliovirus RNA polymerase 3D in Escherichia coli by cleavage of fusion proteins expressed from cloned viral cDNA. Virology 161:348-356.
34. Schechter, I., and A. Berger. 1967. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:157-162.
35. Seipelt, J., A. Guarne, E. Bergmann, M. James, W. Sommergruber, I. Fita, and T. Skern. 1999. The structures of picornaviral proteinases. Virus Res. 62:159-168.
36. Sutmoller, P., S. S. Barteling, R. C. Clascoaga, and K. J. Sumption. 2003. Control and eradication of foot-and-mouth disease. Virus Res. 91:101-144.
37. Taliani, M., E. Bianchi, F. Narjes, M. Fossatelli, A. Urbani, C. Steinkuhler, R. De Francesco, and A. Pessi. 1996. A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Anal. Biochem. 240:60-67.
38. Yin, J., E. M. Bergmann, M. M. Cherney, M. S. Lall, R. P. Jain, J. C. Vederas, and M. N. James. 2005. Dual modes of modification of hepatitis A virus 3C protease by a serine-derived beta-lactone: selective crystallization and formation of a functional catalytic triad in the active site. J. Mol. Biol. 354:854-871.